Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $19.75 USD
Change Today +0.92 / 4.89%
Volume 1.1M
SUPN On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frederick M. Hudson

Director and Chairman of Audit Committee,Supernus Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 4 different organizations across 5 different industries.

See Board Relationships


Mr. Frederick M. Hudson served as a Partner of KPMG LLP since January 1, 2006 and served at it for 37-years. Mr. Hudson was in charge of the Health Care Practice for the Mid-Atlantic Area. He joined Peat Marwick Mitchell & Co. (KPMG s predecessor) in 1969, and was admitted as a Partner in 1975. During his 37 year career at KPMG, he held a number of leadership positions and served a variety of hospital based health systems, including Bon Secours Health System, Sheppard ...

Read Full Background

Corporate Headquarters*

1550 East Gude Drive
Rockville, Maryland 20850

United States

Phone: 301-838-2500
Fax: --

Board Members Memberships*

Director and Chairman of Audit Committee
Director and Chairman of Audit Committee


Loyola University Maryland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options5,312
Unexercisable Options5,313
Total Number of Options10,625

Total Compensation*

Total Annual Cash Compensation$32,500
Total Calculated Compensation$107,258
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SUPN:US $19.75 USD +0.92


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.0M GBP
Thomas B. King Chief Executive Officer, President and Director
Alexza Pharmaceuticals Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUPERNUS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at